articleTop 1% cited
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology · 2022 · Vol. 34(1) · pp. 10–32
Andrés Cervantes✉(Universitat de València)R. Adam(Université Paris-Saclay)Susana Roselló(Universitat de València)Dirk Arnold(Asklepios)Nicola Normanno(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")Julien Taı̈eb(Université Paris Cité)Jenny F. Seligmann(University of Leeds)Thierry de Baère(Inserm)Pia Österlund(Karolinska University Hospital)Takayuki Yoshino(National Cancer Center Hospital East)Erika Martinelli(University of Campania "Luigi Vanvitelli")
Colorectal Cancer Treatments and StudiesColorectal Cancer Screening and DetectionColorectal Cancer Surgical TreatmentsMedicineGuidelineColorectal cancerOncologyCancerClinical PracticeInternal medicineFamily medicinePathology
MeSH terms
Colonic NeoplasmsFollow-Up StudiesHumansRectal NeoplasmsColorectal Neoplasms
Citations
1,496
FWCI
143.03
field-weighted impact
References
167
Percentile
100%
vs. same field & year
Citations per year
References
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
New England Journal of Medicine · 2015 · 9,308 citations
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Annals of Oncology · 2012 · 1,518 citations
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
Journal of Clinical Oncology · 2007 · 1,996 citations
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2014 · 1,183 citations
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Journal of Clinical Oncology · 2008 · 3,144 citations
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
Journal of Clinical Oncology · 2000 · 3,810 citations
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
Journal of Clinical Oncology · 2007 · 2,267 citations
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Journal of Clinical Oncology · 2008 · 2,958 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.